WuXi Biologics WKN: A2QJCN ISIN: KYG970081173 Forum: Aktien User: Summer.76

WuXi Biologics Wins 2021 CMO Leadership Awards in All Six Core Categories https://www.prnewswire.com/news-releases/wuxi-biologics-wins-2021-cmo-leadership-awards-in-all-six-core-categories-301235088.html ...today announced that the company has been named a winner of the 2021 CMO Leadership Awards for a fourth year in a row. The company is proud to receive this distinction in all six award categories – capabilities, compatibility, expertise, quality, reliability, and service – and across the three respondent groups - Big Pharma, Small Pharma, and Overall (combined Big and Small Pharma).   ...

Allgemein zum Markt: Hong Kong stocks sink in biggest sell-off since May as city raises trading fees, mainland funds exit by record amounts https://sg.news.yahoo.com/hong-kong-stocks-sink-biggest-025724314.html Hong Kong stocks suffered the biggest sell-off in nine months amid rising volatility as traders dumped richly-valued popular bets, brushing aside optimistic economic outlook and dov ish comments from the Federal Reserve. A government plan to raise stock trading fees spooked investors. ...

WuXi Biologics (02269) sold 150,000 shares in a big lot, with a transaction price of $104.9 and an investment of 15.74 million http://www.aastocks.com/tc/stocks/news/aamm-news/AAT2102243697/1 [Large deal] WuXi Biologics (02269) sold a large deal at 10:25 in the morning, with a turnover of 150,000 and a transaction price of HK$104.9, involving an investment of 15.74 million.  So far, the stock price has fallen 1.959%. The highest price today is $109.4 and the lowest price is $104.6. The total trading volume is 871372 shares and the total trading value is HK$932.7 million.

BRIEF-JPMorgan Chase & Co's Long Position In WuXi Biologics Falls To 6.65% - HKEX Filing https://pub.webull.com/us/news-html/b3006a4930d044e5a4b1ae5300cc72e8.html?theme=2&_v=1&color=1&hl=en&sp=1&_v=1&theme=2&color=1&hl=en JPMORGAN CHASE & CO'S LONG POSITION IN WUXI BIOLOGICS 2269 HK DECREASED TO 6.65% ON FEB 17 FROM 9.04% - HKEX FILING https://di.hkex.com.hk/di/NSForm2.aspx?fn=CS20210222E00137&sa2=ns&sid=174136&sd=22/02/2020&ed=22/02/2021&sa1=cl&scsd=22/02/2020&sced=22/02/2021&sc=02269&src=Main&lang=EN&tk=ds

https://m.news.sina.com.tw/article/20210222/37683548.html WuXi Biologics (02269 HK) fell ...% after being previously reduced by US Capital Group’s 3.761 million shares, involving approximately HK$458 million in capital;...

BRIEF-JPMorgan Chase & Co's Long Position In Wuxi Biologics Increases To 10.03% - Filings https://pub.webull.com/us/news-html/249372f5fb37453da83a0f20cd4aee40.html?theme=2&_v=1&color=1&hl=en&sp=1&_v=1&theme=2&color=1&hl=en JPMORGAN CHASE & CO'S LONG POSITION IN WUXI BIOLOGICS 2269.HK INCREASED TO 10.03% BETWEEN FEB 8 AND FEB 9 FROM 6.71% - HKEX FILINGS ...

Ja das meinte ich ...nach den ganzen Impfrallyes hätte ich gerne wieder etwas stabileres :D Danke für den Hinweis...werde hier noch die Seitwärtsbewegung und ekne eventuelle Korrektur abwarten und einsteigen.

Meinst du die heißen Eisen, die potenzielle Raketen hervorbringen? WuXi ist eine CDMO und andere Unternehmen nutzen ihre Technologieplattform. Im Bericht vom 18.01. aus dem Kölner Stadtanzeiger (im Chat hinterlegt) findest du eine ganz gute Zusammenfassung zu ihr.

Hm, scheint eine stabile Anlage zu sein...haben die konkret heiße Eisen im Feuer, da der Kurs so abgeht? oÔ

Wegen der Feiertage war heute nur verkürzter Handel in HK. Weiter geht es dort dann wieder am Dienstag.

Meines Erachtens sollte das durch sein, aber schau sonst noch mal in die Meldung von Anfang Februar.

Bekommt man als derzeitiger Aktionär Kaufoptionen ?

WuXi Biologics (02269.HK) allots 118 million shares https://m.jrj.com.cn/madapter/hk/2021/02/10164031883743.shtml WuXi Biologics (02269.HK) announced that it will allot and issue 1.18 on February 10, 2021 in accordance with the general authorization to place new shares as disclosed in the company’s announcement dated February 3, 2021 100 million shares at an issue price of HK$112 per share. https://doc.irasia.com/listco/hk/wuxibiologics/announcement/a210210.pdf

The World's Largest 36,000L Biomanufacturing Line Using Single-use Bioreactors Launches GMP Operation at WuXi Biologics https://www.prnewswire.com/news-releases/the-worlds-largest-36-000l-biomanufacturing-line-using-single-use-bioreactors-launches-gmp-operation-at-wuxi-biologics-301224382.html • Greatly increase the company's current capacity to 90,000L and enable WuXi Biologics to initiate any project within four weeks • Offer flexible large-scale manufacturing services by implementing Scale-out strategy ...

Guten Morgen, 2 verkürzte Handelswochen stehen bevor, da Freitag und kommenden Montag die Börse in Hongkong geschlossen hat. Hier läuft der Handel natürlich weiter. Einen guten Wochenstart 🍀

Daiwa Restates Buy on WUXI BIO (02269.HK), TP $135: Better Captures COVID-19 Vaccine Demands post Placing http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1073972/company-news Daiwa mentioned in its research report that WUXI BIO (02269 HK) had announced the fourth round of new share placement, from which the drugmaker can strengthen the fiscal position to better seize the potential outsourcing demands of mRNA-based vaccines against novel coronavirus. The broker restated Buy on WUXI BIO at the target price $135.